Tudor Investment Corp
TRML

Tudor Investment Corp’s Tourmaline Bio TRML Stock Holding History

Tudor Investment Corp’s Portfolio TRML Stock Details TRML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-13,312
Closed -$305K – 2803
2024
Q1 		$305K Buy
+13,312
New +$469K ﹤0.01% 1849
2022
Q3 		– Sell
-4,249
Closed -$192K – 2717
2022
Q2 		$192K Sell
4,249
-1,250
-23% -$98.6K 0.01% 1833
2022
Q1 		$541K Buy
5,499
+57
+1% +$5.33K 0.01% 1229
2021
Q4 		$832K Sell
5,442
-4,341
-44% -$642K 0.01% 1123
2021
Q3 		$1.33M Sell
9,783
-112
-1% -$15.3K 0.02% 965
2021
Q2 		$1.45M Buy
+9,895
New +$1.52M 0.03% 698

Other funds holding TRML

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Tudor Investment Corp's TRML Position: Q2 2024 in Review

Tudor Investment Corp sold out of Tourmaline Bio (TRML) in Q2 2024, closing a stake of 13,312 shares — an estimated $305K sold.

Tudor Investment Corp first reported a position in TRML in Q2 2021 and held it in 6 quarters. The position peaked at $1.45M in Q2 2021. 84 funds tracked by Wall St. Rank hold TRML as of Q2 2024.

  • Tudor Investment Corp reported no remaining Tourmaline Bio position as of Q2 2024 after selling out during the quarter.
  • Tudor Investment Corp sold 13,312 Tourmaline Bio shares in Q2 2024, an estimated $305K.
  • Tudor Investment Corp first reported a position in Tourmaline Bio in Q2 2021 and held it in 6 quarters.
  • Tudor Investment Corp's Tourmaline Bio position peaked at $1.45M in Q2 2021.
  • 84 funds tracked by Wall St. Rank held Tourmaline Bio as of Q2 2024.

Based on Tudor Investment Corp's 13F filing for Q2 2024, filed 14 Aug 2024.